Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

Australian CEOs are often shy to talk about how and when they use external consultants. The boss of this big French company, ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

Nebraska hospitals currently struggle with lagging reimbursement rates, higher labor costs and aggressive practices from ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Developed and launched in just 21 days, Porch Light Health saw an 11% increase in new patients in the first month of the ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show gains.

Plus: A judge upholds the guilty plea of Trump co-defendant Kenneth Chesebro in the Georgia election case. Is Biden trying to ...

A mental health epidemic among the young, with over half of those under 30 struggling with significant mental health issues, ...